Jun 30, 2022 | Bankruptcy | Dublin | Highly Addictive Opioids | Mallinckrodt | Opioid Abatement | Pharmaceutical Company | Consumer Protection | Division of Consumer Affairs | Division of Law | Fighting the Opioid Crisis | NJ CARES | Press Release
As Part of Mallinckrodt Bankruptcy Plan, New Jersey and its Subdivisions to Receive Approximately $30 Million Dollars from Dublin-Based Pharmaceutical Company that Flooded Market with Highly Addictive Opioid Painkillers, Downplayed Risks For Immediate Release: June...